series-c-plus
Stage
1
Investors
About
Rocket Pharmaceuticals develops gene therapy treatments for rare genetic diseases, focusing on cardiac and bone marrow-derived disorders such as Danon Disease and Fanconi Anemia.
Explore Rocket Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.